2017-09-15 Bayer receives positive CHMP opinion for rivaroxaban 10 mg once daily for the extended prevention of venous thromboembolism
2017-09-14 Bayer receives FDA approval for Copanlisib in adults with relapsed follicular lymphoma after two prior systemic therapies
2017-09-11 Bayer and Vanderbilt University Medical Center collaborate to develop therapies against kidney diseases
2017-09-07 Bayer submits marketing authorization application for BAY94-9027 for the treatment of Hemophilia A in the EU
